Short Wave The Science Behind The Historic mRNA Vaccine
Dec 17, 2020
The podcast delves into the groundbreaking mRNA technology behind the Pfizer-BioNTech COVID-19 vaccine, recently authorized for emergency use. It reveals the rapid development process, highlighting how global collaboration and prior research accelerated its rollout. Experts explain the vaccine’s efficacy and how it instructs the immune system without using the virus. Additionally, the discussion touches on the unique cold storage requirements for mRNA vaccines, showcasing the logistical hurdles faced during distribution.
AI Snips
Chapters
Transcript
Episode notes
mRNA Vaccine Authorization
- The FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine.
- This is the first mRNA vaccine authorized in the U.S., marking a historic moment.
mRNA Technology History
- mRNA vaccine technology has existed since the 90s but wasn't widely used until now.
- The COVID-19 pandemic accelerated the maturation and application of this technology.
Rapid Vaccine Development
- Development was fast because scientists had the virus's genetic sequence early.
- Emergency Use Authorization also expedited the process compared to standard approvals.